HistCite - Trojanowski w/citing papers

Add FileX ?

Use wildcard '*' to add more than one file at a time. For example, if you have file1, file2, etc. all in the same folder or directory; first, locate one of the files with the [Browse...] button. Then alter the file path in the box above to include '*' character (eg. file*). Wildcard '?' to blanket only one character works too.
Note: In Windows you can select multiple files and "drag and drop" them onto HistCite icon or shortcut. The program would start and load those files.

#	Date / Author / Journal	LCS	GCS	LCR	CR
2002
11301	11301 David DC, Layfield R, Serpell L, Narain Y, Goedert M, et al. Proteasomal degradation of tau protein JOURNAL OF NEUROCHEMISTRY. 2002 OCT; 83 (1): 176-185	60	103	21	56
11302	11302 Gozal E, Gozal D, Pierce WM, Thongboonkerd V, Scherzer JA, et al. Proteomic analysis of CA1 and CA3 regions of rat hippocampus and differential susceptibility to intermittent hypoxia JOURNAL OF NEUROCHEMISTRY. 2002 OCT; 83 (2): 331-345	1	49	11	90
11303	11303 Lee G, Junn E, Tanaka M, Kim YM, Lee SS, et al. Synphilin-1 degradation by the ubiquitin-proteasome pathway and effects on cell survival JOURNAL OF NEUROCHEMISTRY. 2002 OCT; 83 (2): 346-352	16	21	21	29
11304	11304 Pitsi D, Kienlen-Campard P, Octave JN Failure of the interaction between presenilin 1 and the substrate of gamma-secretase to produce A beta in insect cells JOURNAL OF NEUROCHEMISTRY. 2002 OCT; 83 (2): 390-399	1	7	7	52
11305	11305 Foltynie T, Sawcer S, Brayne C, Barker RA The genetic basis of Parkinson's disease JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY. 2002 OCT; 73 (4): 363-370	7	26	21	99
11306	11306 Lu DY, Li Y, Mahmood A, Wang L, Rafiq T, et al. Neural and marrow-derived stromal cell sphere transplantation in a rat model of traumatic brain injury JOURNAL OF NEUROSURGERY. 2002 OCT; 97 (4): 935-940	14	34	3	29
11307	11307 Marklund N, Sihver S, Langstrom B, Bergstrom M, Hillered L Effect of traumatic brain injury and nitrone radical scavengers on relative changes in regional cerebral blood flow and glucose uptake in rats JOURNAL OF NEUROTRAUMA. 2002 OCT; 19 (10): 1139-1153	6	16	5	94
11308	11308 Knoblach SM, Nikolaeva M, Huang XL, Fan L, Krajewski S, et al. Multiple caspases are activated after traumatic brain injury: Evidence for involvement in functional outcome JOURNAL OF NEUROTRAUMA. 2002 OCT; 19 (10): 1155-1170	21	44	20	69
11309	11309 Leclercq PD, Stephenson MS, Murray LS, McIntosh TK, Graham DI, et al. Simple morphometry of axonal swellings cannot be used in isolation for dating lesions after traumatic brain injury JOURNAL OF NEUROTRAUMA. 2002 OCT; 19 (10): 1183-1192	2	5	11	42
11310	11310 Achim C, Auer R, Bergeron C, Cardozo A, Deprez M, et al. Global democratic consensus on neuropathological disease criteria LANCET NEUROLOGY. 2002 OCT; 1 (6): 340-340	1	1	0	0
#	Date / Author / Journal	LCS	GCS	LCR	CR
11311	11311 Burn DJ, Lee AJ Progressive supranuclear palsy: where are we now? LANCET NEUROLOGY. 2002 OCT; 1 (6): 359-369	16	46	34	127
11312	11312 Rideout HJ, Stefanis L Proteasomal inhibition-induced inclusion formation and death in cortical neurons require transcription and ubiquitination MOLECULAR AND CELLULAR NEUROSCIENCE. 2002 OCT; 21 (2): 223-238	32	65	38	74
11313	11313 Ehrengruber MU Alphaviral vectors for gene transfer into neurons MOLECULAR NEUROBIOLOGY. 2002 OCT-DEC; 26 (2-3): 183-201	0	18	3	91
11314	11314 Echeverria V, Cuello AC Intracellular A-beta amyloid, a sign for worse things to come? MOLECULAR NEUROBIOLOGY. 2002 OCT-DEC; 26 (2-3): 299-316	12	41	58	188
11315	11315 Thomas EA, Sutcliffe JG The neuirobiology of Apolipoproteins in psychiatric disorders MOLECULAR NEUROBIOLOGY. 2002 OCT-DEC; 26 (2-3): 369-388	1	13	8	115
11316	11316 Wrensch M, Minn Y, Chew T, Bondy M, Berger MS Epidemiology of primary brain tumors: Current concepts and review of the literature NEURO-ONCOLOGY. 2002 OCT; 4 (4): 278-299	5	182	2	214
11317	11317 Narr KL, van Erp TGM, Cannon TD, Woods RP, Thompson PM, et al. A twin study of genetic contributions to hippocampal morphology in schizophrenia NEUROBIOLOGY OF DISEASE. 2002 OCT; 11 (1): 83-95	11	60	10	61
11318	11318 Bonelli RM, Aschoff A, Niederwieser G, Heuberger C, Jirikowski G Cerebrospinal fluid tissue transglutaminase as a biochemical marker for Alzheimer's disease NEUROBIOLOGY OF DISEASE. 2002 OCT; 11 (1): 106-110	7	26	13	38
11319	11319 Nagai A, Suzuki Y, Baek SY, Lee KS, Lee MC, et al. Generation and characterization of human hybrid neurons produced between embryonic CNS neurons and neuroblastoma cells NEUROBIOLOGY OF DISEASE. 2002 OCT; 11 (1): 184-198	0	14	6	41
11320	11320 Yu ZF, Cheng GJ, Wen XM, Wu GD, Lee WT, et al. Tumor necrosis factor alpha increases neuronal vulnerability to excitotoxic necrosis by inducing expression of the AMPA-glutamate receptor subunit GluR1 via an acid sphingomyelinase- and NF-kappa B- dependent mechanism NEUROBIOLOGY OF DISEASE. 2002 OCT; 11 (1): 199-213	2	28	3	96
#	Date / Author / Journal	LCS	GCS	LCR	CR
11321	11321 Ginsberg SD, Che SL RNA amplification in brain tissues NEUROCHEMICAL RESEARCH. 2002 OCT; 27 (10): 981-992	30	52	14	64
11322	11322 Van Deerlin VMD, Gill LH, Nelson PT Optimizing gene expression analysis in archival brain tissue NEUROCHEMICAL RESEARCH. 2002 OCT; 27 (10): 993-1003	5	22	6	71
11323	11323 Sendera TJ, Dorris D, Ramakrishnan R, Nguyen A, Trakas D, et al. Expression profiling with oligonucleotide arrays: Technologies and applications for neurobiology NEUROCHEMICAL RESEARCH. 2002 OCT; 27 (10): 1005-1026	1	7	6	79
11324	11324 Mufson EJ, Counts SE, Ginsberg SD Gene expression profiles of cholinergic nucleus basalis neurons in Alzheimer's disease NEUROCHEMICAL RESEARCH. 2002 OCT; 27 (10): 1035-1048	54	64	20	97
11325	11325 Pongrac J, Middleton FA, Lewis DA, Levitt P, Mirnics K Gene expression profiling with DNA microarrays: Advancing our understanding of psychiatric disorders NEUROCHEMICAL RESEARCH. 2002 OCT; 27 (10): 1049-1063	26	74	13	135
11326	11326 Alder J, Thakker-Varia S, Black IB Transcriptional analysis in the brain: Trophin-induced hippocampal synaptic plasticity NEUROCHEMICAL RESEARCH. 2002 OCT; 27 (10): 1079-1092	0	2	8	84
11327	11327 Jin K, Mao XO, Eshoo MW, del Rio G, Rao R, et al. cDNA microarray analysis of changes in gene expression induced by neuronal hypoxia in vitro NEUROCHEMICAL RESEARCH. 2002 OCT; 27 (10): 1105-1112	2	36	4	78
11328	11328 Marciano PG, Eberwine JH, Ragupathi R, Saatman KE, Meaney DF, et al. Expression profiling following traumatic brain injury: A review NEUROCHEMICAL RESEARCH. 2002 OCT; 27 (10): 1147-1155	8	17	9	91
11329	11329 Tolnay M, Probst A Frontotemporal lobar degeneration - tau as a pied piper? NEUROGENETICS. 2002 OCT; 4 (2): 63-75	20	24	53	124
11330	11330 Lloyd SE, Uphill JB, Targonski PV, Fisher EMC, Collinge J Identification of genetic loci affecting mouse-adapted bovine spongiform encephalopathy incubation time in mice NEUROGENETICS. 2002 OCT; 4 (2): 77-81	4	35	1	27
#	Date / Author / Journal	LCS	GCS	LCR	CR
11331	11331 Avella AMB, Teruel BM, Rodriguez JJL, Viera NG, Martinez IB, et al. A novel presenilin 1 mutation (L174 M) in a large Cuban family with early onset Alzheimer disease NEUROGENETICS. 2002 OCT; 4 (2): 97-104	3	4	3	39
11332	11332 Kjaer TW, Nowak M, Lou HC Reflective self-awareness and conscious states: PET evidence for a common midline parietofrontal core NEUROIMAGE. 2002 OCT; 17 (2): 1080-1086	1	103	3	35
11333	11333 Hardy J Pathways to primary neurodegenerative disease NEUROLOGIA. 2002 OCT; 17 (8): 399-401	2	2	9	21
11334	11334 Rodriguez-Martin E, Casarejos MJ, Canals S, de Bernardo S, Mena MA Thiolic antioxidants protect from nitric oxide-induced toxicity in fetal midbrain cultures NEUROPHARMACOLOGY. 2002 OCT; 43 (5): 877-888	4	26	3	57
11335	11335 Yoshihara Y Visualizing selective neural pathways with WGA transgene: combination of neuroanatomy with gene technology NEUROSCIENCE RESEARCH. 2002 OCT; 44 (2): 133-140	2	19	9	58
11336	11336 Bacskai BJ, Hyman BT Alzheimer's disease: What multiphoton microscopy teaches us NEUROSCIENTIST. 2002 OCT; 8 (5): 386-390	2	8	4	21
11337	11337 Redmond DE Cellular replacement therapy for Parkinson's disease - Where we are today? NEUROSCIENTIST. 2002 OCT; 8 (5): 457-488	21	34	30	332
11338	11338 Cash AD, Perry G, Ogawa O, Raina AK, Zhu XW, et al. Is Alzheimer's disease a mitochondrial disorder? NEUROSCIENTIST. 2002 OCT; 8 (5): 489-496	6	22	13	59
11339	11339 Riess P, Zhang C, Saatman KE, Laurer HL, Longhi LG, et al. Transplanted neural stem cells survive, differentiate, and improve neurological motor function after experimental traumatic brain injury NEUROSURGERY. 2002 OCT; 51 (4): 1043-1052	36	77	13	50
11340	11340 Langston JW Parkinson's disease: Current and future challenges NEUROTOXICOLOGY. 2002 OCT; 23 (4-5): 443-450	3	25	11	43
#	Date / Author / Journal	LCS	GCS	LCR	CR
11341	11341 Trojanowski JQ, Lee VMY Parkinson's disease and related synucleinopathies are a new class of nervous system amyloidoses NEUROTOXICOLOGY. 2002 OCT; 23 (4-5): 457-460	35	35	15	18
11342	11342 Masliah E, Hashimoto M Development of new treatments for Parkinson's disease in transgenic animal models: A role for beta-synuclein NEUROTOXICOLOGY. 2002 OCT; 23 (4-5): 461-468	10	16	41	58
11343	11343 Sanchez-Pernaute R, Brownell A, Isacson O Functional imaging of the dopamine system: In vivo evaluation of dopamine deficiency and restoration NEUROTOXICOLOGY. 2002 OCT; 23 (4-5): 469-478	3	6	2	84
11344	11344 Di Monte DA, Lavasani M, Manning-Bog AB Environmental factors in Parkinson's disease NEUROTOXICOLOGY. 2002 OCT; 23 (4-5): 487-502	25	86	8	161
11345	11345 Skipper L, Farrer M Parkinson's genetics: Molecular insights for the new millennium NEUROTOXICOLOGY. 2002 OCT; 23 (4-5): 503-514	6	16	49	134
11346	11346 Uversky VN, Li J, Bower K, Fink AL Synergistic effects of pesticides and metals on the fibrillation of alpha-synuclein: Implications for Parkinson's disease NEUROTOXICOLOGY. 2002 OCT; 23 (4-5): 527-536	41	64	19	38
11347	11347 Li J, Uversky VN, Fink AL Conformational behavior of human alpha-synuclein is modulated by familial Parkinson's disease point mutations A30P and A53T NEUROTOXICOLOGY. 2002 OCT; 23 (4-5): 553-567	38	47	22	61
11348	11348 Mazzola JL, Sirover MA Alteration of intracellular structure and function of glyceraldehyde-3- phosphate dehydrogenase: A common phenotype of neurodegenerative disorders? NEUROTOXICOLOGY. 2002 OCT; 23 (4-5): 603-609	4	42	12	61
11349	11349 Jolly RD, Schraa I, Halsey TR Progressive ataxia and seizures in a Cocker Spaniel: a new type of neurodegenerative disease with novel intra-neuronal inclusions NEW ZEALAND VETERINARY JOURNAL. 2002 OCT; 50 (5): 203-206	0	0	4	10
11350	11350 Martin A, Youdim K, Szprengiel A, Shukitt-Hale B, Joseph J Roles of vitamins E and C on neurodegenerative diseases and cognitive performance NUTRITION REVIEWS. 2002 OCT; 60 (10): 308-326	2	22	7	199
#	Date / Author / Journal	LCS	GCS	LCR	CR
11351	11351 Yeiser EC, Vanlandingham JW, Levenson CW Moderate zinc deficiency increases cell death after brain injury in the rat NUTRITIONAL NEUROSCIENCE. 2002 OCT; 5 (5): 345-352	2	7	8	50
11352	11352 Sampaio C, Ferreira JJ, Costa J Evidence-based medicine (EBM) applied to Parkinson's disease treatment PARKINSONISM & RELATED DISORDERS. 2002 OCT; 9 (1): 7-13	0	3	1	30
11353	11353 Steele JC, Caparros-Lefebvre D, Lees AJ, Sacks OW Progressive supranuclear palsy and its relation to pacific foci of the parkinsonism-dementia complex and Guadeloupean parkinsonism PARKINSONISM & RELATED DISORDERS. 2002 OCT; 9 (1): 39-54	9	18	7	92
11354	11354 Kimura T, Fujise N, Ono T, Shono M, Yuzuriha T, et al. Identification of an aging-related spherical inclusion in the human brain PATHOLOGY INTERNATIONAL. 2002 OCT; 52 (10): 636-642	1	2	7	16
11355	11355 Isaacs H I. Perinatal brain tumors: A review of 250 cases PEDIATRIC NEUROLOGY. 2002 OCT; 27 (4): 249-261	0	41	8	121
11356	11356 Gurvich N, Klein PS Lithium and valproic acid: parallels and contrasts in diverse signaling contexts PHARMACOLOGY & THERAPEUTICS. 2002 OCT; 96 (1): 45-66	3	70	16	295
11357	11357 Auld DS, Kornecook TJ, Bastianetto S, Quirion R Alzheimer's disease and the basal forebrain cholinergic system: relations to beta-amyloid peptides, cognition, and treatment strategies PROGRESS IN NEUROBIOLOGY. 2002 OCT; 68 (3): 209-245	25	168	28	506
11358	11358 Warter JM, Steinmetz G, Mohr M, Tranchant C Prion diseases REVUE NEUROLOGIQUE. 2002 OCT; 158 (10): 998-1007	0	2	8	87
11359	11359 London AJ, Kadane JB Placebos that harm: sham surgery controls in clinical trials STATISTICAL METHODS IN MEDICAL RESEARCH. 2002 OCT; 11 (5): 413-427	13	27	1	26
11360	11360 Avishai-Eliner S, Brunson KL, Sandman CA, Baram TZ Stressed-out, or in (utero)? TRENDS IN NEUROSCIENCES. 2002 OCT; 25 (10): 518-524	3	122	5	86
#	Date / Author / Journal	LCS	GCS	LCR	CR
11361	11361 Coleman MP, Perry VH Axon pathology in neurological disease: a neglected therapeutic target TRENDS IN NEUROSCIENCES. 2002 OCT; 25 (10): 532-537	21	174	17	74
11362	11362 Park SM, Jung HY, Kim HO, Rhim H, Paik SR, et al. Evidence that alpha-synuclein functions as a negative regulator of Ca+ +-dependent alpha-granule release from human platelets BLOOD. 2002 OCT 1; 100 (7): 2506-2514	15	18	27	59
11363	11363 Lotharius J, Brundin P Impaired dopamine storage resulting from alpha-synuclein mutations may contribute to the pathogenesis of Parkinson's disease HUMAN MOLECULAR GENETICS. 2002 OCT 1; 11 (20): 2395-2407	70	100	56	179
11364	11364 Heutink P, Oostra BA Gene finding in genetically isolated populations HUMAN MOLECULAR GENETICS. 2002 OCT 1; 11 (20): 2507-2515	1	49	7	84
11365	11365 Kazemi-Esfarjani P, Benzer S Suppression of polyglutamine toxicity by a Drosophila homolog of myeloid leukemia factor 1 HUMAN MOLECULAR GENETICS. 2002 OCT 1; 11 (21): 2657-2672	11	34	25	75
11366	11366 Gelinas S, Martinoli MG Neuroprotective effect of estradiol and phytoestrogens on MPP+-induced cytotoxicity in neuronal PC12 cells JOURNAL OF NEUROSCIENCE RESEARCH. 2002 OCT 1; 70 (1): 90-96	8	64	5	64
11367	11367 Marmorstein LHY, Munier FL, Arsenijevic Y, Schorderet DF, McLaughlin PJ, et al. Aberrant accumulation of EFEMP1 underlies drusen formation in Malattia Leventinese and age-related macular degeneration PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA. 2002 OCT 1; 99 (20): 13067-13072	3	53	2	26
11368	11368 Prat R, Galeano I, Conde FJ, Febles P, Cortes S Cerebral neuroblastomas: Diagnosis and treatment REVISTA DE NEUROLOGIA. 2002 OCT 1; 35 (7): 688-690	0	1	4	39
11369	11369 Rajkowska G, Miguel-Hidalgo JJ, Makkos Z, Meltzer H, Overholser J, et al. Layer-specific reductions in GFAP-reactive astroglia in the dorsolateral prefrontal cortex in schizophrenia SCHIZOPHRENIA RESEARCH. 2002 OCT 1; 57 (2-3): 127-138	17	64	9	53
11370	11370 Dormont D Prion diseases: pathogenesis and public health concerns FEBS LETTERS. 2002 OCT 2; 529 (1): 17-21	0	20	2	50
#	Date / Author / Journal	LCS	GCS	LCR	CR
11371	11371 Lashuel HA, Petre BM, Wall J, Simon M, Nowak RJ, et al. alpha-synuclein, especially the Parkinson's disease-associated mutants, forms pore-like annular and tubular protofibrils JOURNAL OF MOLECULAR BIOLOGY. 2002 OCT 4; 322 (5): 1089-1102	172	259	19	47
11372	11372 Brunetti L, Orlando G, Michelotto B, Recinella L, Di Nisio C, et al. Identification of 8-iso-prostaglandin F-2 alpha in rat brain neuronal endings: a possible marker of membrane phospholipid peroxidation LIFE SCIENCES. 2002 OCT 4; 71 (20): 2447-2455	3	4	4	26
11373	11373 Bounias M, Purdey M Transmissible spongiform encephalopathies: a family of etiologically complex diseases - a review SCIENCE OF THE TOTAL ENVIRONMENT. 2002 OCT 7; 297 (1-3): 1-19	0	11	10	148
11374	11374 Galvin JE, Lee SL, Perry A, Havlioglu N, McKeel DW, et al. Familial dementia with Lewy bodies - Clinicopatholdgic analysis of two kindreds NEUROLOGY. 2002 OCT 8; 59 (7): 1079-1082	15	17	4	10
11375	11375 Clarke DJ, Branton RL IL-1 beta is released from the host brain following transplantation but does not compromise embryonic dopaminergic neuron survival BRAIN RESEARCH. 2002 OCT 11; 952 (1): 78-85	1	2	4	54
11376	11376 Lotharius J, Barg S, Wiekop P, Lundberg C, Raymon HK, et al. Effect of mutant alpha-synuclein on dopamine homeostasis in a new human mesencephalic cell line JOURNAL OF BIOLOGICAL CHEMISTRY. 2002 OCT 11; 277 (41): 38884-38894	76	107	36	89
11377	11377 Lusher ME, Lindsey JC, Latif F, Pearson ADJ, Ellison DW, et al. Biallelic epigenetic inactivation of the RASSF1A tumor suppressor gene in medulloblastoma development CANCER RESEARCH. 2002 OCT 15; 62 (20): 5906-5911	13	48	4	29
11378	11378 Kuo YH, Chen TT Novel activities of pro-IGF-I E peptides: Regulation of morphological differentiation and anchorage-independent growth in human neuroblastoma cells EXPERIMENTAL CELL RESEARCH. 2002 OCT 15; 280 (1): 75-89	0	26	5	68
11379	11379 Cabin DE, Shimazu K, Murphy D, Cole NB, Gottschalk W, et al. Synaptic vesicle depletion correlates with attenuated synaptic responses to prolonged repetitive stimulation in mice lacking alpha- synuclein JOURNAL OF NEUROSCIENCE. 2002 OCT 15; 22 (20): 8797-8807	226	268	12	45
11380	11380 Luciano RL, Wilson AC An activation domain in the C-terminal subunit of HCF-1 is important for transactivation by VP16 and LZIP PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA. 2002 OCT 15; 99 (21): 13403-13408	2	25	1	50
#	Date / Author / Journal	LCS	GCS	LCR	CR
11381	11381 Tatebayashi Y, Miyasaka T, Chui DH, Akagi T, Mishima K, et al. Tau filament formation and associative memory deficit in aged mice expressing mutant (R406W) human tau PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA. 2002 OCT 15; 99 (21): 13896-13901	94	105	24	31
11382	11382 DeKosky ST Neurobiology and molecular biology of Alzheimer's disease REVISTA DE NEUROLOGIA. 2002 OCT 16; 35 (8): 752-760	0	0	16	126
11383	11383 del Ser T Dementia with Lewy bodies. Pure and mixed forms REVISTA DE NEUROLOGIA. 2002 OCT 16; 35 (8): 761-765	1	2	14	64
11384	11384 Hamilton RL Recent advances in the neuropathological evaluation of Alzheimer's disease: The importance of alpha-synuclein REVISTA DE NEUROLOGIA. 2002 OCT 16; 35 (8): 765-767	0	0	7	15
11385	11385 Woodruff-Pak DS, Green JT, Pak JT, Shiotani T, Watabe S, et al. The long-term effects of nefiracetam on learning in older rabbits BEHAVIOURAL BRAIN RESEARCH. 2002 OCT 17; 136 (1): 299-308	0	2	1	39
11386	11386 Kirst A, Wack C, Lutz WK, Eggert A, Kampgen E, et al. Expression of functional kappa-opioid receptors on murine dendritic cells IMMUNOLOGY LETTERS. 2002 OCT 21; 84 (1): 41-48	0	12	3	44
11387	11387 Bennett DA, McDermott MP Cerebrospinal fluid shunting for Alzheimer's disease? NEUROLOGY. 2002 OCT 22; 59 (8): 1126-1127	0	1	6	14
11388	11388 Liu F, Iqbal K, Grundke-Iqbal I, Gong CX Involvement of aberrant glycosylation in phosphorylation of tau by cdk5 and GSK-3 beta FEBS LETTERS. 2002 OCT 23; 530 (1-3): 209-214	26	54	38	54
11389	11389 Costigan M, Befort K, Karchewski L, Griffin RS, D'Urso D, et al. Replicate high-density rat genome oligonucleotide microarrays reveal hundreds of regulated genes in the dorsal root ganglion after peripheral nerve injury. BMC NEUROSCIENCE. 2002 OCT 25; 3: Art. No. 16	3	168	7	138
11390	11390 Opazo C, Huang XD, Cherny RA, Moir RD, Roher AE, et al. Metalloenzyme-like activity of Alzheimer's disease beta-amyloid - Cu- dependent catalytic conversion of dopamine, cholesterol, and biological reducing agents to neurotoxic H2O2 JOURNAL OF BIOLOGICAL CHEMISTRY. 2002 OCT 25; 277 (43): 40302-40308	54	224	8	47
#	Date / Author / Journal	LCS	GCS	LCR	CR
11391	11391 Rao MV, Engle LJ, Mohan PS, Yuan AD, Qiu DK, et al. Myosin Va binding to neurofilaments is essential for correct myosin Va distribution and transport and neurofilament density JOURNAL OF CELL BIOLOGY. 2002 OCT 28; 159 (2): 279-289	14	56	12	50
11392	11392 Fride E, Shohami E The endocannabinoid system: function in survival of the embryo, the newborn and the neuron NEUROREPORT. 2002 OCT 28; 13 (15): 1833-1841	0	22	2	173
11393	11393 Kang SH, Lee YA, Won SJ, Rhee KH, Gwag BJ Caffeine-induced neuronal death in neonatal rat brain and cortical cell cultures NEUROREPORT. 2002 OCT 28; 13 (15): 1945-1950	0	10	1	24
11394	11394 Sarang SS, Yoshida T, Cadet R, Valeras AS, Jensen RV, et al. Discovery of molecular mechanisms of neuroprotection using cell-based bioassays and oligonucleotide arrays PHYSIOLOGICAL GENOMICS. 2002 OCT 29; 11 (2): 45-52	1	19	8	64
11395	11395 Steece-Collier K, Maries E, Kordower JH Etiology of Parkinson's disease: Genetics and environment revisited PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA. 2002 OCT 29; 99 (22): 13972-13974	17	29	27	38
11396	11396 Dauer W, Kholodilov N, Vila M, Trillat AC, Goodchild R, et al. Resistance of alpha-synuclein null mice to the parkinsonian neurotoxin MPTP PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA. 2002 OCT 29; 99 (22): 14524-14529	161	206	13	37
11397	11397 Taktakishvili O, Sivan-Loukianova E, Kultas-Ilinsky K, Ilinsky IA Posterior parietal cortex projections to the ventral lateral and some association thalamic nuclei in Macaca mulatta BRAIN RESEARCH BULLETIN. 2002 OCT 30; 59 (2): 135-150	1	11	11	67
11398	11398 Mori F, Hayashi S, Yamagishi S, Yoshimoto M, Yagihashi S, et al. Pick's disease: alpha- and beta-synuclein-immunoreactive Pick bodies in the dentate gyrus ACTA NEUROPATHOLOGICA. 2002 NOV; 104 (5): 455-461	11	13	36	43
11399	11399 Holzer M, Gartner U, Stobe A, Hartig W, Gruschka H, et al. Inverse association of Pin1 and tau accumulation in Alzheimer's disease hippocampus ACTA NEUROPATHOLOGICA. 2002 NOV; 104 (5): 471-481	17	33	31	77
11400	11400 Mochizuki A, Komatsuzaki Y, Shoji S Association of Lewy bodies and glial cytoplasmic inclusions in the brain of Parkinson's disease ACTA NEUROPATHOLOGICA. 2002 NOV; 104 (5): 534-537	10	10	8	13

Date / Author / Journal

LCS

GCS

LCR

2002

11301

11301 David DC, Layfield R, Serpell L, Narain Y, Goedert M, et al.

Proteasomal degradation of tau protein

JOURNAL OF NEUROCHEMISTRY. 2002 OCT; 83 (1): 176-185

103

11302

11302 Gozal E, Gozal D, Pierce WM, Thongboonkerd V, Scherzer JA, et al.

Proteomic analysis of CA1 and CA3 regions of rat hippocampus and differential susceptibility to intermittent hypoxia

JOURNAL OF NEUROCHEMISTRY. 2002 OCT; 83 (2): 331-345

11303

11303 Lee G, Junn E, Tanaka M, Kim YM, Lee SS, et al.

Synphilin-1 degradation by the ubiquitin-proteasome pathway and effects on cell survival

JOURNAL OF NEUROCHEMISTRY. 2002 OCT; 83 (2): 346-352

11304

11304 Pitsi D, Kienlen-Campard P, Octave JN

Failure of the interaction between presenilin 1 and the substrate of gamma-secretase to produce A beta in insect cells

JOURNAL OF NEUROCHEMISTRY. 2002 OCT; 83 (2): 390-399

11305

11305 Foltynie T, Sawcer S, Brayne C, Barker RA

The genetic basis of Parkinson's disease

JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY. 2002 OCT; 73 (4): 363-370

11306

11306 Lu DY, Li Y, Mahmood A, Wang L, Rafiq T, et al.

Neural and marrow-derived stromal cell sphere transplantation in a rat model of traumatic brain injury

JOURNAL OF NEUROSURGERY. 2002 OCT; 97 (4): 935-940

11307

11307 Marklund N, Sihver S, Langstrom B, Bergstrom M, Hillered L

Effect of traumatic brain injury and nitrone radical scavengers on relative changes in regional cerebral blood flow and glucose uptake in rats

JOURNAL OF NEUROTRAUMA. 2002 OCT; 19 (10): 1139-1153

11308

11308 Knoblach SM, Nikolaeva M, Huang XL, Fan L, Krajewski S, et al.

Multiple caspases are activated after traumatic brain injury: Evidence for involvement in functional outcome

JOURNAL OF NEUROTRAUMA. 2002 OCT; 19 (10): 1155-1170

11309

11309 Leclercq PD, Stephenson MS, Murray LS, McIntosh TK, Graham DI, et al.

Simple morphometry of axonal swellings cannot be used in isolation for dating lesions after traumatic brain injury

JOURNAL OF NEUROTRAUMA. 2002 OCT; 19 (10): 1183-1192

11310

11310 Achim C, Auer R, Bergeron C, Cardozo A, Deprez M, et al.

Global democratic consensus on neuropathological disease criteria

LANCET NEUROLOGY. 2002 OCT; 1 (6): 340-340

Date / Author / Journal

LCS

GCS

LCR

11311

11311 Burn DJ, Lee AJ

Progressive supranuclear palsy: where are we now?

LANCET NEUROLOGY. 2002 OCT; 1 (6): 359-369

127

11312

11312 Rideout HJ, Stefanis L

Proteasomal inhibition-induced inclusion formation and death in cortical neurons require transcription and ubiquitination

MOLECULAR AND CELLULAR NEUROSCIENCE. 2002 OCT; 21 (2): 223-238

11313

11313 Ehrengruber MU

Alphaviral vectors for gene transfer into neurons

MOLECULAR NEUROBIOLOGY. 2002 OCT-DEC; 26 (2-3): 183-201

11314

11314 Echeverria V, Cuello AC

Intracellular A-beta amyloid, a sign for worse things to come?

MOLECULAR NEUROBIOLOGY. 2002 OCT-DEC; 26 (2-3): 299-316

188

11315

11315 Thomas EA, Sutcliffe JG

The neuirobiology of Apolipoproteins in psychiatric disorders

MOLECULAR NEUROBIOLOGY. 2002 OCT-DEC; 26 (2-3): 369-388

115

11316

11316 Wrensch M, Minn Y, Chew T, Bondy M, Berger MS

Epidemiology of primary brain tumors: Current concepts and review of the literature

NEURO-ONCOLOGY. 2002 OCT; 4 (4): 278-299

182

214

11317

11317 Narr KL, van Erp TGM, Cannon TD, Woods RP, Thompson PM, et al.

A twin study of genetic contributions to hippocampal morphology in schizophrenia

NEUROBIOLOGY OF DISEASE. 2002 OCT; 11 (1): 83-95

11318

11318 Bonelli RM, Aschoff A, Niederwieser G, Heuberger C, Jirikowski G

Cerebrospinal fluid tissue transglutaminase as a biochemical marker for Alzheimer's disease

NEUROBIOLOGY OF DISEASE. 2002 OCT; 11 (1): 106-110

11319

11319 Nagai A, Suzuki Y, Baek SY, Lee KS, Lee MC, et al.

Generation and characterization of human hybrid neurons produced between embryonic CNS neurons and neuroblastoma cells

NEUROBIOLOGY OF DISEASE. 2002 OCT; 11 (1): 184-198

11320

11320 Yu ZF, Cheng GJ, Wen XM, Wu GD, Lee WT, et al.

Tumor necrosis factor alpha increases neuronal vulnerability to excitotoxic necrosis by inducing expression of the AMPA-glutamate receptor subunit GluR1 via an acid sphingomyelinase- and NF-kappa B- dependent mechanism

NEUROBIOLOGY OF DISEASE. 2002 OCT; 11 (1): 199-213

Date / Author / Journal

LCS

GCS

LCR

11321

11321 Ginsberg SD, Che SL

RNA amplification in brain tissues

NEUROCHEMICAL RESEARCH. 2002 OCT; 27 (10): 981-992

11322

11322 Van Deerlin VMD, Gill LH, Nelson PT

Optimizing gene expression analysis in archival brain tissue

NEUROCHEMICAL RESEARCH. 2002 OCT; 27 (10): 993-1003

11323

11323 Sendera TJ, Dorris D, Ramakrishnan R, Nguyen A, Trakas D, et al.

Expression profiling with oligonucleotide arrays: Technologies and applications for neurobiology

NEUROCHEMICAL RESEARCH. 2002 OCT; 27 (10): 1005-1026

11324

11324 Mufson EJ, Counts SE, Ginsberg SD

Gene expression profiles of cholinergic nucleus basalis neurons in Alzheimer's disease

NEUROCHEMICAL RESEARCH. 2002 OCT; 27 (10): 1035-1048

11325

11325 Pongrac J, Middleton FA, Lewis DA, Levitt P, Mirnics K

Gene expression profiling with DNA microarrays: Advancing our understanding of psychiatric disorders

NEUROCHEMICAL RESEARCH. 2002 OCT; 27 (10): 1049-1063

135

11326

11326 Alder J, Thakker-Varia S, Black IB

Transcriptional analysis in the brain: Trophin-induced hippocampal synaptic plasticity

NEUROCHEMICAL RESEARCH. 2002 OCT; 27 (10): 1079-1092

11327

11327 Jin K, Mao XO, Eshoo MW, del Rio G, Rao R, et al.

cDNA microarray analysis of changes in gene expression induced by neuronal hypoxia in vitro

NEUROCHEMICAL RESEARCH. 2002 OCT; 27 (10): 1105-1112

11328

11328 Marciano PG, Eberwine JH, Ragupathi R, Saatman KE, Meaney DF, et al.

Expression profiling following traumatic brain injury: A review

NEUROCHEMICAL RESEARCH. 2002 OCT; 27 (10): 1147-1155

11329

11329 Tolnay M, Probst A

Frontotemporal lobar degeneration - tau as a pied piper?

NEUROGENETICS. 2002 OCT; 4 (2): 63-75

124

11330

11330 Lloyd SE, Uphill JB, Targonski PV, Fisher EMC, Collinge J

Identification of genetic loci affecting mouse-adapted bovine spongiform encephalopathy incubation time in mice

NEUROGENETICS. 2002 OCT; 4 (2): 77-81

Date / Author / Journal

LCS

GCS

LCR

11331

11331 Avella AMB, Teruel BM, Rodriguez JJL, Viera NG, Martinez IB, et al.

A novel presenilin 1 mutation (L174 M) in a large Cuban family with early onset Alzheimer disease

NEUROGENETICS. 2002 OCT; 4 (2): 97-104

11332

11332 Kjaer TW, Nowak M, Lou HC

Reflective self-awareness and conscious states: PET evidence for a common midline parietofrontal core

NEUROIMAGE. 2002 OCT; 17 (2): 1080-1086

103

11333

11333 Hardy J

Pathways to primary neurodegenerative disease

NEUROLOGIA. 2002 OCT; 17 (8): 399-401

11334

11334 Rodriguez-Martin E, Casarejos MJ, Canals S, de Bernardo S, Mena MA

Thiolic antioxidants protect from nitric oxide-induced toxicity in fetal midbrain cultures

NEUROPHARMACOLOGY. 2002 OCT; 43 (5): 877-888

11335

11335 Yoshihara Y

Visualizing selective neural pathways with WGA transgene: combination of neuroanatomy with gene technology

NEUROSCIENCE RESEARCH. 2002 OCT; 44 (2): 133-140

11336

11336 Bacskai BJ, Hyman BT

Alzheimer's disease: What multiphoton microscopy teaches us

NEUROSCIENTIST. 2002 OCT; 8 (5): 386-390

11337

11337 Redmond DE

Cellular replacement therapy for Parkinson's disease - Where we are today?

NEUROSCIENTIST. 2002 OCT; 8 (5): 457-488

332

11338

11338 Cash AD, Perry G, Ogawa O, Raina AK, Zhu XW, et al.

Is Alzheimer's disease a mitochondrial disorder?

NEUROSCIENTIST. 2002 OCT; 8 (5): 489-496

11339

11339 Riess P, Zhang C, Saatman KE, Laurer HL, Longhi LG, et al.

Transplanted neural stem cells survive, differentiate, and improve neurological motor function after experimental traumatic brain injury

NEUROSURGERY. 2002 OCT; 51 (4): 1043-1052

11340

11340 Langston JW

Parkinson's disease: Current and future challenges

NEUROTOXICOLOGY. 2002 OCT; 23 (4-5): 443-450

Date / Author / Journal

LCS

GCS

LCR

11341

11341 Trojanowski JQ, Lee VMY

Parkinson's disease and related synucleinopathies are a new class of nervous system amyloidoses

NEUROTOXICOLOGY. 2002 OCT; 23 (4-5): 457-460

11342

11342 Masliah E, Hashimoto M

Development of new treatments for Parkinson's disease in transgenic animal models: A role for beta-synuclein

NEUROTOXICOLOGY. 2002 OCT; 23 (4-5): 461-468

11343

11343 Sanchez-Pernaute R, Brownell A, Isacson O

Functional imaging of the dopamine system: In vivo evaluation of dopamine deficiency and restoration

NEUROTOXICOLOGY. 2002 OCT; 23 (4-5): 469-478

11344

11344 Di Monte DA, Lavasani M, Manning-Bog AB

Environmental factors in Parkinson's disease

NEUROTOXICOLOGY. 2002 OCT; 23 (4-5): 487-502

161

11345

11345 Skipper L, Farrer M

Parkinson's genetics: Molecular insights for the new millennium

NEUROTOXICOLOGY. 2002 OCT; 23 (4-5): 503-514

134

11346

11346 Uversky VN, Li J, Bower K, Fink AL

Synergistic effects of pesticides and metals on the fibrillation of alpha-synuclein: Implications for Parkinson's disease

NEUROTOXICOLOGY. 2002 OCT; 23 (4-5): 527-536

11347

11347 Li J, Uversky VN, Fink AL

Conformational behavior of human alpha-synuclein is modulated by familial Parkinson's disease point mutations A30P and A53T

NEUROTOXICOLOGY. 2002 OCT; 23 (4-5): 553-567

11348

11348 Mazzola JL, Sirover MA

Alteration of intracellular structure and function of glyceraldehyde-3- phosphate dehydrogenase: A common phenotype of neurodegenerative disorders?

NEUROTOXICOLOGY. 2002 OCT; 23 (4-5): 603-609

11349

11349 Jolly RD, Schraa I, Halsey TR

Progressive ataxia and seizures in a Cocker Spaniel: a new type of neurodegenerative disease with novel intra-neuronal inclusions

NEW ZEALAND VETERINARY JOURNAL. 2002 OCT; 50 (5): 203-206

11350

11350 Martin A, Youdim K, Szprengiel A, Shukitt-Hale B, Joseph J

Roles of vitamins E and C on neurodegenerative diseases and cognitive performance

NUTRITION REVIEWS. 2002 OCT; 60 (10): 308-326

199

Date / Author / Journal

LCS

GCS

LCR

11351

11351 Yeiser EC, Vanlandingham JW, Levenson CW

Moderate zinc deficiency increases cell death after brain injury in the rat

NUTRITIONAL NEUROSCIENCE. 2002 OCT; 5 (5): 345-352

11352

11352 Sampaio C, Ferreira JJ, Costa J

Evidence-based medicine (EBM) applied to Parkinson's disease treatment

PARKINSONISM & RELATED DISORDERS. 2002 OCT; 9 (1): 7-13

11353

11353 Steele JC, Caparros-Lefebvre D, Lees AJ, Sacks OW

Progressive supranuclear palsy and its relation to pacific foci of the parkinsonism-dementia complex and Guadeloupean parkinsonism

PARKINSONISM & RELATED DISORDERS. 2002 OCT; 9 (1): 39-54

11354

11354 Kimura T, Fujise N, Ono T, Shono M, Yuzuriha T, et al.

Identification of an aging-related spherical inclusion in the human brain

PATHOLOGY INTERNATIONAL. 2002 OCT; 52 (10): 636-642

11355

11355 Isaacs H

I. Perinatal brain tumors: A review of 250 cases

PEDIATRIC NEUROLOGY. 2002 OCT; 27 (4): 249-261

121

11356

11356 Gurvich N, Klein PS

Lithium and valproic acid: parallels and contrasts in diverse signaling contexts

PHARMACOLOGY & THERAPEUTICS. 2002 OCT; 96 (1): 45-66

295

11357

11357 Auld DS, Kornecook TJ, Bastianetto S, Quirion R

Alzheimer's disease and the basal forebrain cholinergic system: relations to beta-amyloid peptides, cognition, and treatment strategies

PROGRESS IN NEUROBIOLOGY. 2002 OCT; 68 (3): 209-245

168

506

11358

11358 Warter JM, Steinmetz G, Mohr M, Tranchant C

Prion diseases

REVUE NEUROLOGIQUE. 2002 OCT; 158 (10): 998-1007

11359

11359 London AJ, Kadane JB

Placebos that harm: sham surgery controls in clinical trials

STATISTICAL METHODS IN MEDICAL RESEARCH. 2002 OCT; 11 (5): 413-427

11360

11360 Avishai-Eliner S, Brunson KL, Sandman CA, Baram TZ

Stressed-out, or in (utero)?

TRENDS IN NEUROSCIENCES. 2002 OCT; 25 (10): 518-524

122

Date / Author / Journal

LCS

GCS

LCR

11361

11361 Coleman MP, Perry VH

Axon pathology in neurological disease: a neglected therapeutic target

TRENDS IN NEUROSCIENCES. 2002 OCT; 25 (10): 532-537

174

11362

11362 Park SM, Jung HY, Kim HO, Rhim H, Paik SR, et al.

Evidence that alpha-synuclein functions as a negative regulator of Ca+ +-dependent alpha-granule release from human platelets

BLOOD. 2002 OCT 1; 100 (7): 2506-2514

11363

11363 Lotharius J, Brundin P

Impaired dopamine storage resulting from alpha-synuclein mutations may contribute to the pathogenesis of Parkinson's disease

HUMAN MOLECULAR GENETICS. 2002 OCT 1; 11 (20): 2395-2407

100

179

11364

11364 Heutink P, Oostra BA

Gene finding in genetically isolated populations

HUMAN MOLECULAR GENETICS. 2002 OCT 1; 11 (20): 2507-2515

11365

11365 Kazemi-Esfarjani P, Benzer S

Suppression of polyglutamine toxicity by a Drosophila homolog of myeloid leukemia factor 1

HUMAN MOLECULAR GENETICS. 2002 OCT 1; 11 (21): 2657-2672

11366

11366 Gelinas S, Martinoli MG

Neuroprotective effect of estradiol and phytoestrogens on MPP+-induced cytotoxicity in neuronal PC12 cells

JOURNAL OF NEUROSCIENCE RESEARCH. 2002 OCT 1; 70 (1): 90-96

11367

11367 Marmorstein LHY, Munier FL, Arsenijevic Y, Schorderet DF, McLaughlin PJ, et al.

Aberrant accumulation of EFEMP1 underlies drusen formation in Malattia Leventinese and age-related macular degeneration

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA. 2002 OCT 1; 99 (20): 13067-13072

11368

11368 Prat R, Galeano I, Conde FJ, Febles P, Cortes S

Cerebral neuroblastomas: Diagnosis and treatment

REVISTA DE NEUROLOGIA. 2002 OCT 1; 35 (7): 688-690

11369

11369 Rajkowska G, Miguel-Hidalgo JJ, Makkos Z, Meltzer H, Overholser J, et al.

Layer-specific reductions in GFAP-reactive astroglia in the dorsolateral prefrontal cortex in schizophrenia

SCHIZOPHRENIA RESEARCH. 2002 OCT 1; 57 (2-3): 127-138

11370

11370 Dormont D

Prion diseases: pathogenesis and public health concerns

FEBS LETTERS. 2002 OCT 2; 529 (1): 17-21

Date / Author / Journal

LCS

GCS

LCR

11371

11371 Lashuel HA, Petre BM, Wall J, Simon M, Nowak RJ, et al.

alpha-synuclein, especially the Parkinson's disease-associated mutants, forms pore-like annular and tubular protofibrils

JOURNAL OF MOLECULAR BIOLOGY. 2002 OCT 4; 322 (5): 1089-1102

172

259

11372

11372 Brunetti L, Orlando G, Michelotto B, Recinella L, Di Nisio C, et al.

Identification of 8-iso-prostaglandin F-2 alpha in rat brain neuronal endings: a possible marker of membrane phospholipid peroxidation

LIFE SCIENCES. 2002 OCT 4; 71 (20): 2447-2455

11373

11373 Bounias M, Purdey M

Transmissible spongiform encephalopathies: a family of etiologically complex diseases - a review

SCIENCE OF THE TOTAL ENVIRONMENT. 2002 OCT 7; 297 (1-3): 1-19

148

11374

11374 Galvin JE, Lee SL, Perry A, Havlioglu N, McKeel DW, et al.

Familial dementia with Lewy bodies - Clinicopatholdgic analysis of two kindreds

NEUROLOGY. 2002 OCT 8; 59 (7): 1079-1082

11375

11375 Clarke DJ, Branton RL

IL-1 beta is released from the host brain following transplantation but does not compromise embryonic dopaminergic neuron survival

BRAIN RESEARCH. 2002 OCT 11; 952 (1): 78-85

11376

11376 Lotharius J, Barg S, Wiekop P, Lundberg C, Raymon HK, et al.

Effect of mutant alpha-synuclein on dopamine homeostasis in a new human mesencephalic cell line

JOURNAL OF BIOLOGICAL CHEMISTRY. 2002 OCT 11; 277 (41): 38884-38894

107

11377

11377 Lusher ME, Lindsey JC, Latif F, Pearson ADJ, Ellison DW, et al.

Biallelic epigenetic inactivation of the RASSF1A tumor suppressor gene in medulloblastoma development

CANCER RESEARCH. 2002 OCT 15; 62 (20): 5906-5911

11378

11378 Kuo YH, Chen TT

Novel activities of pro-IGF-I E peptides: Regulation of morphological differentiation and anchorage-independent growth in human neuroblastoma cells

EXPERIMENTAL CELL RESEARCH. 2002 OCT 15; 280 (1): 75-89

11379

11379 Cabin DE, Shimazu K, Murphy D, Cole NB, Gottschalk W, et al.

Synaptic vesicle depletion correlates with attenuated synaptic responses to prolonged repetitive stimulation in mice lacking alpha- synuclein

JOURNAL OF NEUROSCIENCE. 2002 OCT 15; 22 (20): 8797-8807

226

268

11380

11380 Luciano RL, Wilson AC

An activation domain in the C-terminal subunit of HCF-1 is important for transactivation by VP16 and LZIP

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA. 2002 OCT 15; 99 (21): 13403-13408

Date / Author / Journal

LCS

GCS

LCR

11381

11381 Tatebayashi Y, Miyasaka T, Chui DH, Akagi T, Mishima K, et al.

Tau filament formation and associative memory deficit in aged mice expressing mutant (R406W) human tau

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA. 2002 OCT 15; 99 (21): 13896-13901

105

11382

11382 DeKosky ST

Neurobiology and molecular biology of Alzheimer's disease

REVISTA DE NEUROLOGIA. 2002 OCT 16; 35 (8): 752-760

126

11383

11383 del Ser T

Dementia with Lewy bodies. Pure and mixed forms

REVISTA DE NEUROLOGIA. 2002 OCT 16; 35 (8): 761-765

11384

11384 Hamilton RL

Recent advances in the neuropathological evaluation of Alzheimer's disease: The importance of alpha-synuclein

REVISTA DE NEUROLOGIA. 2002 OCT 16; 35 (8): 765-767

11385

11385 Woodruff-Pak DS, Green JT, Pak JT, Shiotani T, Watabe S, et al.

The long-term effects of nefiracetam on learning in older rabbits

BEHAVIOURAL BRAIN RESEARCH. 2002 OCT 17; 136 (1): 299-308

11386

11386 Kirst A, Wack C, Lutz WK, Eggert A, Kampgen E, et al.

Expression of functional kappa-opioid receptors on murine dendritic cells

IMMUNOLOGY LETTERS. 2002 OCT 21; 84 (1): 41-48

11387

11387 Bennett DA, McDermott MP

Cerebrospinal fluid shunting for Alzheimer's disease?

NEUROLOGY. 2002 OCT 22; 59 (8): 1126-1127

11388

11388 Liu F, Iqbal K, Grundke-Iqbal I, Gong CX

Involvement of aberrant glycosylation in phosphorylation of tau by cdk5 and GSK-3 beta

FEBS LETTERS. 2002 OCT 23; 530 (1-3): 209-214

11389

11389 Costigan M, Befort K, Karchewski L, Griffin RS, D'Urso D, et al.

Replicate high-density rat genome oligonucleotide microarrays reveal hundreds of regulated genes in the dorsal root ganglion after peripheral nerve injury.

BMC NEUROSCIENCE. 2002 OCT 25; 3: Art. No. 16

168

138

11390

11390 Opazo C, Huang XD, Cherny RA, Moir RD, Roher AE, et al.

Metalloenzyme-like activity of Alzheimer's disease beta-amyloid - Cu- dependent catalytic conversion of dopamine, cholesterol, and biological reducing agents to neurotoxic H2O2

JOURNAL OF BIOLOGICAL CHEMISTRY. 2002 OCT 25; 277 (43): 40302-40308

224

Date / Author / Journal

LCS

GCS

LCR

11391

11391 Rao MV, Engle LJ, Mohan PS, Yuan AD, Qiu DK, et al.

Myosin Va binding to neurofilaments is essential for correct myosin Va distribution and transport and neurofilament density

JOURNAL OF CELL BIOLOGY. 2002 OCT 28; 159 (2): 279-289

11392

11392 Fride E, Shohami E

The endocannabinoid system: function in survival of the embryo, the newborn and the neuron

NEUROREPORT. 2002 OCT 28; 13 (15): 1833-1841

173

11393

11393 Kang SH, Lee YA, Won SJ, Rhee KH, Gwag BJ

Caffeine-induced neuronal death in neonatal rat brain and cortical cell cultures

NEUROREPORT. 2002 OCT 28; 13 (15): 1945-1950

11394

11394 Sarang SS, Yoshida T, Cadet R, Valeras AS, Jensen RV, et al.

Discovery of molecular mechanisms of neuroprotection using cell-based bioassays and oligonucleotide arrays

PHYSIOLOGICAL GENOMICS. 2002 OCT 29; 11 (2): 45-52

11395

11395 Steece-Collier K, Maries E, Kordower JH

Etiology of Parkinson's disease: Genetics and environment revisited

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA. 2002 OCT 29; 99 (22): 13972-13974

11396

11396 Dauer W, Kholodilov N, Vila M, Trillat AC, Goodchild R, et al.

Resistance of alpha-synuclein null mice to the parkinsonian neurotoxin MPTP

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA. 2002 OCT 29; 99 (22): 14524-14529

161

206

11397

11397 Taktakishvili O, Sivan-Loukianova E, Kultas-Ilinsky K, Ilinsky IA

Posterior parietal cortex projections to the ventral lateral and some association thalamic nuclei in Macaca mulatta

BRAIN RESEARCH BULLETIN. 2002 OCT 30; 59 (2): 135-150

11398

11398 Mori F, Hayashi S, Yamagishi S, Yoshimoto M, Yagihashi S, et al.

Pick's disease: alpha- and beta-synuclein-immunoreactive Pick bodies in the dentate gyrus

ACTA NEUROPATHOLOGICA. 2002 NOV; 104 (5): 455-461

11399

11399 Holzer M, Gartner U, Stobe A, Hartig W, Gruschka H, et al.

Inverse association of Pin1 and tau accumulation in Alzheimer's disease hippocampus

ACTA NEUROPATHOLOGICA. 2002 NOV; 104 (5): 471-481

11400

11400 Mochizuki A, Komatsuzaki Y, Shoji S

Association of Lewy bodies and glial cytoplasmic inclusions in the brain of Parkinson's disease

ACTA NEUROPATHOLOGICA. 2002 NOV; 104 (5): 534-537

Trojanowski w/citing papers Publications by JQ Trojanowski and the papers citing JQ Trojanowski	Historiographs	Glossary HistCite Guide About Grand Totals: LCS 336329, GCS 1007154, CR 1762209 Collection span: 1973 - 2011
List of All Records